Skip to main content

UBS Reaffirms Their Hold Rating on Pediatrix Medical Group (MD)

Tipranks - Tipranks - Thu Nov 6, 2025

UBS analyst A.J. Rice maintained a Hold rating on Pediatrix Medical Group today and set a price target of $23.00.

Meet Your ETF AI Analyst

According to TipRanks, Rice is a 5-star analyst with an average return of 8.4% and a 60.22% success rate. Rice covers the Healthcare sector, focusing on stocks such as UnitedHealth, The Ensign Group, and Universal Health.

In addition to UBS, Pediatrix Medical Group also received a Hold from Truist Financial’s David S Macdonald in a report issued yesterday. However, on the same day, TR | OpenAI – 4o upgraded Pediatrix Medical Group (NYSE: MD) to a Buy.

See the top stocks recommended by analysts >>

Based on Pediatrix Medical Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $492.88 million and a net profit of $71.71 million. In comparison, last year the company earned a revenue of $511.16 million and had a net profit of $19.44 million

Read More on MD:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).